Lactobacillus iners is a Gram-positive, facultatively anaerobic bacterium that dominates the vaginal microbiome of many women worldwide, defining Community State Type III (CST-III) in vaginal microbiome classification. For decades, all vaginal Lactobacillus species were assumed to be protective. The accumulating evidence tells a different story: L. iners is increasingly recognized as a dysbiosis marker rather than a guardian of vaginal health.
This distinction matters enormously for clinical interpretation. A vaginal microbiome report showing "Lactobacillus-dominant" is reassuring only if the dominant species is lactobacillus crispatus (CST-I). When L. iners dominates, the microbiome is often in a transitional state — compatible with low diversity, active pathogen colonization, and progression toward bacterial vaginosis or disease.
Metal Dependencies
- Manganese: L. iners relies on manganese-dependent enzymes for oxidative stress defense. Unlike L. crispatus, which produces robust hydrogen peroxide, L. iners produces minimal H2O2 — a critical functional deficit.
- Iron: Required for basic metabolic processes, though L. iners has a streamlined genome with reduced biosynthetic capacity compared to other vaginal lactobacilli.
Key Enzymes and Virulence Factors
The key distinction between L. iners and protective vaginal lactobacilli lies in its enzymatic profile:
- Inerolysin: A cholesterol-dependent cytolysin (CDC) unique to L. iners. This pore-forming toxin can damage vaginal epithelial cells and may contribute to the breakdown of the mucosal barrier. No other vaginal Lactobacillus produces a CDC.
- L-lactate dehydrogenase: L. iners produces only L-lactic acid, whereas L. crispatus produces both D- and L-lactic acid. D-lactic acid is the form with stronger antimicrobial activity and is associated with greater protection against HIV and other sexually transmitted infections.
- Absent H2O2 production: L. iners produces little to no hydrogen peroxide, eliminating a key antimicrobial mechanism that other vaginal lactobacilli use to suppress pathobionts.
- Minimal bacteriocin production: Unlike L. crispatus, L. iners has a reduced genome (~1.3 Mb, among the smallest of lactobacilli) with limited capacity for antimicrobial peptide synthesis.
Ecological Role
L. iners occupies a paradoxical ecological position — it is a Lactobacillus that does not protect:
- Transitional state indicator: L. iners-dominant communities are frequently the transitional state between L. crispatus dominance (healthy) and BV-associated polymicrobial dysbiosis. Women can shift rapidly from CST-III to CST-IV (BV) and back.
- Pathogen permissive: In women with tubal infertility and Chlamydia trachomatis infection, the vaginal microbiota was L. iners-dominated rather than L. crispatus-dominated, with significantly lower Shannon diversity. L. crispatus (not L. iners) is the species that restricts CT colonization (chen 2021 chlamydia vaginal microbiota tubal infertility, case-control, n=25).
- *Failure to suppress S. aureus**: In PCOS vaginal microbiomes, L. iners did not correlate with S. aureus suppression, reinforcing that it lacks the antimicrobial activity of L. crispatus* (zheng 2024 pcos obesity vaginal microbiome phages, cross-sectional).
Conditions Associated
Enriched in:
- Endometriosis: L. iners significantly reduced in endometriosis-associated chronic pelvic pain patients alongside L. jensenii and L. reuteri, while pathogenic Clostridia expanded (chao 2021 vaginal microbiome chronic pelvic pain endometriosis, cross-sectional). Separately, L. iners was implicated in endometriosis vaginal microbiota-N-glycome studies (macsharry 2024 endometriosis vaginal microbiota n glycome, case-control).
- Ovarian cancer (serous histology): L. iners enriched in the lower reproductive tract of serous ovarian cancer patients alongside Facklamia hominis, Anaerococcus senegalensis, and Actinomyces turicensis. Consistent with L. iners as a dysbiosis marker rather than a eubiosis marker (asangba 2023 microbiome ovarian cancer diagnostic prognostic, cross-sectional).
- PCOS: Part of the altered vaginal microbiome in PCOS patients, where shotgun sequencing confirmed dysbiosis with reduced Lactobacillus diversity. Pathobionts including Streptococcus pyogenes and Clostridium perfringens were enriched in PCOS groups (zheng 2024 pcos obesity vaginal microbiome phages, cross-sectional).
- Tubal infertility: L. iners-dominated vaginal microbiota was associated with C. trachomatis infection and significantly lower diversity compared to healthy controls (chen 2021 chlamydia vaginal microbiota tubal infertility, case-control, n=25).
Key Studies
| Study | Finding | Evidence Level |
|---|---|---|
| chen 2021 chlamydia vaginal microbiota tubal infertility | L. iners-dominant in CT-infected infertile women; L. crispatus restricts CT | Case-control |
| zheng 2024 pcos obesity vaginal microbiome phages | No S. aureus suppression; dysbiosis marker in PCOS | Cross-sectional |
| asangba 2023 microbiome ovarian cancer diagnostic prognostic | Enriched in serous OC lower reproductive tract | Cross-sectional |
| chao 2021 vaginal microbiome chronic pelvic pain endometriosis | Reduced in endometriosis-associated CPP | Cross-sectional |
| macsharry 2024 endometriosis vaginal microbiota n glycome | Implicated in endometriosis vaginal dysbiosis | Case-control |
Cross-References
- lactobacillus crispatus — truly protective vaginal Lactobacillus; the standard against which L. iners falls short
- endometriosis — vaginal microbiome disruption
- ovarian cancer — enriched in serous histology
- polycystic-ovary-syndrome — vaginal dysbiosis component
- chlamydia trachomatis — pathogen not suppressed by L. iners
- bacterial vaginosis — transitional state toward BV
- vaginal-microbiome — community state type classification